Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-007971
Filing Date
2024-11-13
Accepted
2024-11-13 16:00:25
Documents
70
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR SEPT 2024 actuate_i10q-093024.htm   iXBRL 10-Q 1486615
2 CERTIFICATION actuate_ex3101.htm EX-31.1 7702
3 CERTIFICATION actuate_ex3102.htm EX-31.2 7688
4 CERTIFICATION actuate_ex3201.htm EX-32.1 6090
  Complete submission text file 0001683168-24-007971.txt   6190568

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE actu-20240930.xsd EX-101.SCH 48604
6 XBRL CALCULATION FILE actu-20240930_cal.xml EX-101.CAL 45679
7 XBRL DEFINITION FILE actu-20240930_def.xml EX-101.DEF 209741
8 XBRL LABEL FILE actu-20240930_lab.xml EX-101.LAB 361668
9 XBRL PRESENTATION FILE actu-20240930_pre.xml EX-101.PRE 338899
72 EXTRACTED XBRL INSTANCE DOCUMENT actuate_i10q-093024_htm.xml XML 790345
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

EIN.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42139 | Film No.: 241453811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)